Cardiovascular
Cardiovascular Research Supported by Proven Clinical Experience
Sequoia supports cardiovascular research across hypertension, heart failure, lipid-lowering therapies, LP(a), and cardiometabolic conditions. Our experienced investigators established patient populations, and proven history of cardiovascular study execution help sponsors confidently advance cardiovascular programs.
Cardiovascular Experience
Sequoia's cardiovascular experience extends across hypertension, heart failure, lipid management, LP(a), and cardiometabolic conditions, supported by investigators with expertise spanning endocrinology, nephrology, and cardiovascular medicine.
- Hypertension
- Heart Failure
- Lipid Lowering
- LP(a)
- Cardiometabolic Outcomes
Patient Access & Study Execution
Successful cardiovascular studies require more than clinical expertise. Sequoia combines established patient populations, experienced recruitment teams, and proven enrollment capabilities to help sponsors meet study goals.
40,000+
participant research database
65,000+
active patient charts
17,000+
patients with BMI >27, supporting cardiometabolic research
19%
of participants age 65+, an important population for many cardiovascular protocols
75–80%
Hispanic and Black patient population across Houston sites, supporting diversity goals
Supporting Investigators
Dr. Heath Wilt is President of the American Heart Association Kansas City Chapter, Chief Medical Director at Meritas Health, and former Cardiology Director at AdventHealth. He is board certified in Internal Medicine and Nuclear Cardiology and is one of Sequoia's experienced investigators supporting cardiovascular research across the network.
Protocol-Specific Capabilities
Depending on protocol requirements, Sequoia provides access to specialized resources including:
PBMC laboratory
Onsite pharmacy
PK/PD support
Inpatient capabilities
NETWORK
Backed by the Sequoia Network
Every cardiovascular study benefits from shared operational support, standardized quality systems, and collaborative investigator expertise.
Five FDA inspections with zero Form 483 findings reflect Sequoia's commitment to consistent quality across every study.
Discuss Your Cardiovascular Study
Connect with Sequoia to explore investigator fit, patient access, and feasibility for your next cardiovascular clinical trial.
Frequently asked questions
What cardiovascular indications does Sequoia support?
Sequoia supports cardiovascular research across hypertension, heart failure, lipid-lowering therapies, LP(a), and broader cardiometabolic conditions.
How does Sequoia recruit cardiovascular patients?
Sequoia recruits cardiovascular patients through centralized recruitment support, experienced local research teams, and an established participant database, helping ensure enrollment commitments are realistic and achievable.
Which investigators support cardiovascular studies?
Cardiovascular studies are supported by Dr. Heath Wilt and Sequoia's growing network of investigators, matched to each protocol's therapeutic focus and patient population.
Can Sequoia support complex cardiovascular protocols?
Yes. Sequoia provides access to specialized resources including a PBMC laboratory, onsite pharmacy, inpatient capabilities, and PK/PD support to help execute complex cardiovascular protocols.